<DOC>
	<DOCNO>NCT01047241</DOCNO>
	<brief_summary>The aim study investigate absorption clinical effect nasal administration analgesic nasal spray contain sufentanil+ketamine pain related medical procedure hospitalize child .</brief_summary>
	<brief_title>Nasal Administration Sufentanil+Ketamine Procedure-related Pain Children</brief_title>
	<detailed_description>The management procedural pain child range physical restraint pharmacological intervention . Pediatric formulation permit accurate dosing , accept child rapid onset analgesia lack . The objective investigate pediatric formulation intranasal sufentanil 0.5 mcg/kg ketamine 0.5 mg/kg procedural pain characterize pharmacokinetic ( PK ) profile . Fifty child ( â‰¥10 kg ) schedule painful procedure include prospective nonrandomized open-label clinical trial . Thirteen child central venous access drug assay sampling ; enable compartmental PK analysis use nonlinear mixed-effects model . Pain intensity procedure measure use age-appropriate pain scale . Heart rate , oxygen saturation sedation record .</detailed_description>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Children adolescent treat University Hospital , Rigshospital Painful medical procedure relate patient treatment Patient and/or parent must able understand speak danish Negative pregnancy test girl , relevant Signed informed consent Only light meal meal ingest 2 hour prior inclusion Allergy sufentanil ketamine Abnormal nasal cavity Have treat sufentanil and/or ketamine last 48 hour Nasal obstruction ( rhinitis )</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Painful medical procedure</keyword>
</DOC>